Provided by Tiger Trade Technology Pte. Ltd.

Definitive Healthcare Corp.

1.05
+0.01000.96%
Post-market: 1.04-0.0100-0.95%19:30 EDT
Volume:602.04K
Turnover:626.36K
Market Cap:112.35M
PE:-0.65
High:1.05
Open:1.02
Low:1.02
Close:1.04
52wk High:4.35
52wk Low:0.6103
Shares:107.00M
Float Shares:38.21M
Volume Ratio:0.27
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6113
EPS(LYR):-1.3027
ROE:-78.37%
ROA:-1.94%
PB:0.78
PE(LYR):-0.81

Loading ...

Analysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH) and Entrada Therapeutics Inc (TRDA)

TIPRANKS
·
Sep 03

Definitive Healthcare Gets Acquisition Interest from Advent International

Dow Jones
·
Sep 02

Definitive Healthcare confirms going-private proposal from Advent International

TIPRANKS
·
Sep 02

Definitive Healthcare Special Committee Receives Advent Go-Private Proposal at $1.02 a Share

Reuters
·
Sep 02

Definitive Healthcare Corp - Proposal Values Class a Common Stock at $1.02 Per Share in All-Cash Deal

THOMSON REUTERS
·
Sep 02

Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

THOMSON REUTERS
·
Sep 02

Definitive Healthcare Corp - Special Committee Formed to Evaluate Potential Deal with Advent International

THOMSON REUTERS
·
Sep 02

Definitive Healthcare CEO Kevin Coop departs, Clay Ritchey succeeds

TIPRANKS
·
Sep 02

Definitive Healthcare Corp - Kevin Coop Departs as CEO and Board Member Effective Aug 31, 2026

THOMSON REUTERS
·
Sep 02

Definitive Healthcare Appoints Clay Ritchey as CEO

GlobeNewswire
·
Sep 02

Barclays Sticks to Their Sell Rating for Definitive Healthcare Corp (DH)

TIPRANKS
·
Aug 24

Definitive Healthcare Earnings Call: Profits Up, Sales Down

TIPRANKS
·
Aug 23

Analysts Conflicted on These Healthcare Names: IDEAYA Biosciences (IDYA) and Definitive Healthcare Corp (DH)

TIPRANKS
·
Aug 20

Veritone Q2 Revenue Misses Estimates

Reuters
·
Aug 14

OptimizeRx Q2 Revenue Beats Estimates on Operating Resilience; Reaffirms Outlook

Reuters
·
Aug 13

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)

TIPRANKS
·
Aug 12

Similarweb Beats Q2 Estimates on AI Demand, Lifts FY Outlook

Reuters
·
Aug 12

Morgan Stanley Adjusts Definitive Healthcare PT to $1.50 From $2.50, Maintains Equalweight Rating

MT Newswires Live
·
Aug 11

Definitive Healthcare : Morgan Stanley Cuts Target Price to $1.50 from $2.50

THOMSON REUTERS
·
Aug 11

Definitive Healthcare Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11